Stock 9995 REMEGEN CO., LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Analyst Reco. RemeGen Co., Ltd.

Equities

9995

CNE1000048G6

Market Closed - Hong Kong S.E.
Other stock markets
 01:38:07 05/07/2024 pm IST 		5-day change 1st Jan Change
21.6 HKD +1.17% Intraday chart for RemeGen Co., Ltd. -11.84% -42.32%
14/06 RemeGen Phase Three Breast Cancer Clinical Trial Meets Primary Endpoint; Shares Rise 3% MT
13/06 RemeGen Co., Ltd. Announces Phase III Clinical Study of Disitamab Vedotin for Injection for the Treatment of HER2-Positive Advanced Breast Cancer with Liver Metastasis Met Primary Study Endpoint CI

Analyst Reco.

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
UBS Adjusts RemeGen's Price Target to HK$75.20 From HK$75.03, Keeps at Buy
MT
UBS Upgrades RemeGen to Buy From Neutral, Adjusts Price Target to HK$75.03 From HK$108
MT
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. 9995 Stock
  4. News RemeGen Co., Ltd.
  5. Analyst Reco.